FCF Margin % is calculated as Free Cash Flow divided by its Revenue. XBiotech's Free Cash Flow for the
three
months ended in Mar. 2024 was $-7.46 Mil. XBiotech's Revenue for the
three
months ended in Mar. 2024 was $0.00 Mil. Therefore, XBiotech's FCF Margin % for the quarter that ended in Mar. 2024 was 0.00%.
The historical rank and industry rank for XBiotech's FCF Margin % or its related term are showing as below:
During the past 12 years, the highest FCF Margin % of XBiotech was 358.38%. The lowest was -384.26%. And the median was -156.55%.
XBIT's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -143.92 * Ranked among companies with meaningful FCF Margin % only.
XBiotech FCF Margin % Historical Data
The historical data trend for XBiotech's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, XBiotech's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
XBiotech's FCF Margin % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, XBiotech's FCF Margin % distribution charts can be found below:
* The bar in red indicates where XBiotech's FCF Margin % falls into.
XBiotech FCF Margin % Calculation
FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.
XBiotech's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XBiotech FCF Margin % Related Terms
Thank you for viewing the detailed overview of XBiotech's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
XBiotech Inc is a United States based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XBIT has been successfully added to your 